by TractManager | Nov 24, 2020 | News
The Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least...
by TractManager | Nov 23, 2020 | News
The World Health Organization (WHO) has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, citing a lack of evidence that remdesivir improves survival and other outcomes in these patients.This...
by TractManager | Nov 23, 2020 | News
The Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for baricitinib (Eli Lilly and Company) in combination with remdesivir for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients...
by TractManager | Nov 23, 2020 | Health Technology Assessment
Focus of the Report: Transperineal template prostate (TTP) biopsy is an alternative to standard transrectal ultrasound (TRUS) biopsy for repeat biopsies. TTP biopsy is a form of saturation biopsy (at least 20 cores) that uses a brachytherapy grid to assure even...
by TractManager | Nov 19, 2020 | News
On November 18, 2020, the National Institutes of Health (NIH) issued a statement on the Food and Drug Administration (FDA) Emergency Use Authorization (EUA) of bamlanivimab for the treatment of COVID-19. Bamlanivimab (Eli Lilly and Company) is a neutralizing...
Recent Comments